188 related articles for article (PubMed ID: 23657628)
1. Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells.
Galvin KC; Dyck L; Marshall NA; Stefanska AM; Walsh KP; Moran B; Higgins SC; Dungan LS; Mills KH
Cancer Immunol Immunother; 2013 Jul; 62(7):1273-82. PubMed ID: 23657628
[TBL] [Abstract][Full Text] [Related]
2. Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.
Conroy H; Galvin KC; Higgins SC; Mills KH
Cancer Immunol Immunother; 2012 Mar; 61(3):425-31. PubMed ID: 22193988
[TBL] [Abstract][Full Text] [Related]
3. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.
Jarnicki AG; Conroy H; Brereton C; Donnelly G; Toomey D; Walsh K; Sweeney C; Leavy O; Fletcher J; Lavelle EC; Dunne P; Mills KH
J Immunol; 2008 Mar; 180(6):3797-806. PubMed ID: 18322186
[TBL] [Abstract][Full Text] [Related]
4. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.
Song S; Zhang K; You H; Wang J; Wang Z; Yan C; Liu F
Clin Exp Immunol; 2010 Oct; 162(1):75-83. PubMed ID: 20735440
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells.
Hill JA; Hall JA; Sun CM; Cai Q; Ghyselinck N; Chambon P; Belkaid Y; Mathis D; Benoist C
Immunity; 2008 Nov; 29(5):758-70. PubMed ID: 19006694
[TBL] [Abstract][Full Text] [Related]
6. Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulation.
Bhanumathy KK; Zhang B; Ahmed KA; Qureshi M; Xie Y; Tao M; Tan X; Xiang J
Int J Mol Sci; 2014 Mar; 15(4):5508-21. PubMed ID: 24690994
[TBL] [Abstract][Full Text] [Related]
7. Anti-PD-1 inhibits Foxp3
Dyck L; Wilk MM; Raverdeau M; Misiak A; Boon L; Mills KH
Cancer Immunol Immunother; 2016 Dec; 65(12):1491-1498. PubMed ID: 27680570
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
[TBL] [Abstract][Full Text] [Related]
9. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
[TBL] [Abstract][Full Text] [Related]
10. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells.
Bakdash G; Vogelpoel LT; van Capel TM; Kapsenberg ML; de Jong EC
Mucosal Immunol; 2015 Mar; 8(2):265-78. PubMed ID: 25027601
[TBL] [Abstract][Full Text] [Related]
12. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A(2B) receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells.
Kaji W; Tanaka S; Tsukimoto M; Kojima S
J Toxicol Sci; 2014 Apr; 39(2):191-8. PubMed ID: 24646699
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells and B cells cooperate in the generation of CD4(+)CD25(+)FOXP3(+) allogeneic T cells.
Moore C; Sauma D; Reyes PA; Morales J; Rosemblatt M; Bono MR; Fierro JA
Transplant Proc; 2010; 42(1):371-5. PubMed ID: 20172352
[TBL] [Abstract][Full Text] [Related]
15. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.
Yamazaki S; Dudziak D; Heidkamp GF; Fiorese C; Bonito AJ; Inaba K; Nussenzweig MC; Steinman RM
J Immunol; 2008 Nov; 181(10):6923-33. PubMed ID: 18981112
[TBL] [Abstract][Full Text] [Related]
16. Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells.
Maynard CL; Hatton RD; Helms WS; Oliver JR; Stephensen CB; Weaver CT
J Exp Med; 2009 Feb; 206(2):343-57. PubMed ID: 19204112
[TBL] [Abstract][Full Text] [Related]
17. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
Uraki R; Imai M; Ito M; Shime H; Odanaka M; Okuda M; Kawaoka Y; Yamazaki S
PLoS Pathog; 2021 Dec; 17(12):e1010085. PubMed ID: 34882757
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors.
Moore C; Sauma D; Morales J; Bono MR; Rosemblatt M; Fierro JA
Transplant Proc; 2009; 41(6):2670-2. PubMed ID: 19715998
[TBL] [Abstract][Full Text] [Related]
19. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.
Hong S; Li H; Qian J; Yang J; Lu Y; Yi Q
Clin Exp Immunol; 2012 Nov; 170(2):167-77. PubMed ID: 23039887
[TBL] [Abstract][Full Text] [Related]
20. CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice.
Wang LX; Li Y; Yang G; Pang PY; Haley D; Walker EB; Urba WJ; Hu HM
Eur J Immunol; 2010 May; 40(5):1375-85. PubMed ID: 20186876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
